LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. It consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide.
LacriJet® has been specifically designed to reduce operating time, eitherin the intubation phase as well as forthe removal of the device.
LacriJet® is first introduced into the nasolacrimal duct. Once in position, the sliding piston is retracted and the silicone intubation is released. It is maintained in place at the punctum by a plug-like fixation head: no nasal retrieval, no knots and no sutures are needed.
The smaller sizes LacriJet® 15 mm and 20 mm have been specifically designed for canalicular laceration repair to prevent future canalicular obstruction due to scar tissue formation.

• Exclusive new injection system
• Silicone tube preloaded inside the metallic guide
• No nasal retrieval
• No knots
• No sutures
• Available in 7 lengths
• 3 mm plug collarette
• Requires sizer(S1.1288)to select the length & 0.3 mm disposable punctum dilator and plug inserter(S1.3090)
• Sterile, Single use

The LacriJet® (Class IIb) is a medical device manufactured by FCI S.A.S. - Notified Body: GMED CE n°0459